SEC Form 4 · accession 0000899243-17-020179
PALVELLA THERAPEUTICS, INC. · PVLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Allan Reine
Officer — See Remarks
Period of report
Aug 9, 2017
Accepted (ET)
Aug 11, 2017 · 9:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common StockF1 | $5.00 | Aug 9, 2017 | A | 450,000 | A | — | Aug 9, 2027 | Common Stock | 450,000 | 450,000 | D |
Explanation of responses
- F1The option vests as to 25% of the option shares on August 9, 2018 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter until August 9, 2021.
Remarks
SVP and Chief Financial Officer